This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Drug Channels Outlook 2021.
Click here to see the original post and comments from October 2020.
Last week, news broke that Prime Therapeutics is expanding its relationship with Cigna’s Express Scripts to include mail and specialty pharmacy dispensing. So far, there's been very little written about this transaction.
Below, I share my thoughts on the following topics arising from the deal:
- The mail and specialty pharmacy market
- The future of AllianceRx Walgreens Prime
- The emerging Express Scripts industry platform
- A reminder about why the Federal Trade Commission won’t challenge the relationship
Prime is becoming increasingly dependent on outsourcing to Cigna’s Express Scripts business. This new pharmacy contract furthers the industry’s move toward vertical consolidation and the disappearance of the independent PBM industry.
Once again, channel intermediaries continue to gain power and extract profits. More to come.
Source: Post feed
